STTCOMP 4DX FA LONG
Medical device - FDA approved and medicare reimbursement amount set - for lung imaging. Partnership with Philips and recently introduced into two medical centres in the USA. Recent cap raise at $0.75 - shares settled on Friday. There's been a number of catalysts over the past month - hopefully this will continue if they continue to successfully roll out the device in the USA.
- Forums
- ASX - Short Term Trading
- Short Term Trading Week Starting: 18 Dec
STTCOMP 4DX FA LONGMedical device - FDA approved and medicare...
Featured News
Featured News
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Dr Michael Thurn, CEO & MD
Dr Michael Thurn
CEO & MD
SPONSORED BY The Market Online